136 related articles for article (PubMed ID: 20881869)
21. Trilateral retinoblastoma: is the location of the intracranial tumor important?
Paulino AC
Cancer; 1999 Jul; 86(1):135-41. PubMed ID: 10391573
[TBL] [Abstract][Full Text] [Related]
22. Thiotepa/topotecan/carboplatin with autologous stem cell rescue in recurrent/refractory/poor prognosis pediatric malignancies of the central nervous system.
Gilheeney SW; Khakoo Y; Souweidane M; Wolden S; Boulad F; Dunkel IJ
Pediatr Blood Cancer; 2010 Apr; 54(4):591-5. PubMed ID: 19998470
[TBL] [Abstract][Full Text] [Related]
23. [Radiotherapy in the multimodality treatment of retinoblastomas in children].
Goldobenko GV; Durnov LA; Lobanov GV; Liutova NA; Belkina BM
Med Radiol (Mosk); 1985 Dec; 30(12):3-7. PubMed ID: 4079688
[TBL] [Abstract][Full Text] [Related]
24. [Combined chemotherapy of CDDP and etoposide in intracranial germinomas].
Mizuno M; Yoshida J; Noda S
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3457-60. PubMed ID: 2802639
[TBL] [Abstract][Full Text] [Related]
25. A multidisciplinary treatment strategy that includes high-dose chemotherapy for metastatic retinoblastoma without CNS involvement.
Matsubara H; Makimoto A; Higa T; Kawamoto H; Sakiyama S; Hosono A; Takayama J; Takaue Y; Murayama S; Sumi M; Kaneko A; Ohira M
Bone Marrow Transplant; 2005 Apr; 35(8):763-6. PubMed ID: 15750608
[TBL] [Abstract][Full Text] [Related]
26. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma.
Dunkel IJ; Khakoo Y; Kernan NA; Gershon T; Gilheeney S; Lyden DC; Wolden SL; Orjuela M; Gardner SL; Abramson DH
Pediatr Blood Cancer; 2010 Jul; 55(1):55-9. PubMed ID: 20486171
[TBL] [Abstract][Full Text] [Related]
27. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
[TBL] [Abstract][Full Text] [Related]
28. Results of a prospective study for the treatment of retinoblastoma.
Chantada G; Fandiño A; Dávila MT; Manzitti J; Raslawski E; Casak S; Schvartzman E
Cancer; 2004 Feb; 100(4):834-42. PubMed ID: 14770442
[TBL] [Abstract][Full Text] [Related]
29. Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma.
Torbidoni AV; Sampor C; Laurent VE; Aschero R; Iyer S; Rossi J; Alderete D; Alonso DF; Szijan I; Chantada GL
Br J Ophthalmol; 2018 Nov; 102(11):1597-1601. PubMed ID: 30150278
[TBL] [Abstract][Full Text] [Related]
30. Trilateral retinoblastoma. A report of five patients.
Amoaku WM; Willshaw HE; Parkes SE; Shah KJ; Mann JR
Cancer; 1996 Aug; 78(4):858-63. PubMed ID: 8756382
[TBL] [Abstract][Full Text] [Related]
31. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
Shields CL; Mashayekhi A; Sun H; Uysal Y; Friere J; Komarnicky L; Shields JA
Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
[TBL] [Abstract][Full Text] [Related]
32. Encouraging result of tamoxifen in a retinoblastoma patient with central nervous system metastasis.
Taçyildiz N; Yavuz G; Unal E; Gündüz K; Günalp I; Ekinci C
Pediatr Hematol Oncol; 2003 Sep; 20(6):473-6. PubMed ID: 14631622
[TBL] [Abstract][Full Text] [Related]
33. Multifaceted chemotherapy for trilateral retinoblastoma.
Dimaras H; Héon E; Doyle J; Strahlendorf C; Paton KE; Halliday W; Babyn P; Gallie BL; Chan HS
Arch Ophthalmol; 2011 Mar; 129(3):362-5. PubMed ID: 21402997
[No Abstract] [Full Text] [Related]
34. High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas.
Gururangan S; McLaughlin C; Quinn J; Rich J; Reardon D; Halperin EC; Herndon J; Fuchs H; George T; Provenzale J; Watral M; McLendon RE; Friedman A; Friedman HS; Kurtzberg J; Vredenbergh J; Martin PL
J Clin Oncol; 2003 Jun; 21(11):2187-91. PubMed ID: 12775745
[TBL] [Abstract][Full Text] [Related]
35. Trilateral retinoblastoma: insights into histogenesis and management.
Marcus DM; Brooks SE; Leff G; McCormick R; Thompson T; Anfinson S; Lasudry J; Albert DM
Surv Ophthalmol; 1998; 43(1):59-70. PubMed ID: 9716194
[TBL] [Abstract][Full Text] [Related]
36. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
37. Metastatic retinoblastoma clinical features, treatment, and prognosis.
Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
[TBL] [Abstract][Full Text] [Related]
38. Trilateral retinoblastoma--incidence and outcome: a decade of experience.
Blach LE; McCormick B; Abramson DH; Ellsworth RM
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):729-33. PubMed ID: 8040018
[TBL] [Abstract][Full Text] [Related]
39. The success of primary chemotherapy for group D heritable retinoblastoma.
Cohen VM; Kingston J; Hungerford JL
Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
[TBL] [Abstract][Full Text] [Related]
40. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
